The Anti-Müllerian Hormone (AMH) test is one of the most commonly requested fertility-related blood tests in Australia, but it sits in an awkward spot in the Medicare system — leading to confusing pricing that catches many patients off guard.
This guide explains the actual cost of an AMH blood test in Australia in 2026, when Medicare will rebate it (and when it will not), the one major lab that bulk-bills it, normal AMH ranges by age, and what an AMH result can — and cannot — tell you about your fertility.
AMH test cost in Australia: the quick answer
| Scenario | Typical cost in 2026 |
|---|---|
| Self-requested / fertility screening at most AU labs | $80–$120 out-of-pocket |
| Doctor-requested for fertility planning (no clinical indication) | $80–$120 out-of-pocket |
| Doctor-requested for PCOS investigation | Medicare rebate may apply — out-of-pocket varies by lab |
| Doctor-requested for premature ovarian insufficiency | Medicare rebate may apply |
| At 4Cyte Pathology with valid Medicare referral | Bulk-billed (no out-of-pocket) |
The most important practical insight: 4Cyte Pathology is the only major Australian pathology provider that bulk-bills AMH testing with a valid Medicare referral. If cost is a concern and you have a referral from your GP, asking to be collected by 4Cyte can save you $80–$120 compared to other major labs (Laverty, Sullivan Nicolaides, Australian Clinical Labs, Dorevitch, QML, Douglass Hanly Moir, Western Diagnostic).
What is the AMH test?
Anti-Müllerian Hormone (AMH) is produced by the granulosa cells of small antral follicles in the ovaries. The more small follicles a woman has, the higher her AMH level. AMH is therefore widely used as a proxy for ovarian reserve — the number of eggs remaining in the ovaries.
AMH has three useful properties that make it the dominant ovarian-reserve marker in Australia:
- Stable across the menstrual cycle — can be tested any day, no fasting required, no timing constraints (unlike FSH/LH which are day-specific).
- Predictive of response to IVF stimulation — fertility specialists use AMH to estimate how many eggs they can expect to retrieve.
- Markedly elevated in PCOS — making it useful in distinguishing PCOS from other causes of irregular cycles.
AMH is measured in pmol/L on Australian reports (some legacy reports use ng/mL — multiply ng/mL by 7.14 to convert).
When Medicare covers AMH testing
This is where it gets complicated. AMH is not on the routine Medicare-rebatable hormone panel (item 66695 covers FSH, LH, oestradiol, prolactin and others — but not AMH). Medicare will rebate AMH testing only when it is ordered to investigate a specific clinical question, including:
- Suspected Polycystic Ovary Syndrome (PCOS) — irregular cycles, hyperandrogenism (acne, hirsutism), or polycystic ovarian morphology on ultrasound
- Premature Ovarian Insufficiency (POI) — women under 40 with absent or irregular periods
- Investigation of certain ovarian tumours (granulosa cell tumours)
- Pre-IVF assessment — under a fertility specialist''s management plan
- Following chemotherapy or radiotherapy — assessing post-treatment ovarian function
What Medicare does not cover: AMH testing requested for general fertility screening in an asymptomatic woman with regular cycles. This includes "I''m turning 35 and want to know where I stand" — a very common reason for testing, but one that has to be paid out of pocket.
If your GP or specialist documents a Medicare-eligible clinical indication on the request form, most labs will apply the rebate. 4Cyte Pathology goes further and bulk-bills AMH with any valid Medicare referral, regardless of indication.
Where AMH is tested in Australia
All major Australian pathology providers offer AMH testing:
- 4Cyte Pathology (VIC/NSW) — only provider that bulk-bills AMH with a valid Medicare referral
- Laverty Pathology (NSW/ACT) — typical out-of-pocket $80–$120
- Sullivan Nicolaides Pathology / SNP (QLD/northern NSW) — typical out-of-pocket $80–$120
- Australian Clinical Labs / ACL (national) — typical out-of-pocket $80–$120
- Dorevitch Pathology (VIC) — typical out-of-pocket $80–$120
- QML Pathology (QLD) — typical out-of-pocket $80–$120
- Douglass Hanly Moir / DHM (NSW) — typical out-of-pocket $80–$120, plus the lab''s standard non-bulk-billing policy
- Western Diagnostic Pathology / WDP (WA/NT) — typical out-of-pocket $80–$120
Prices change quarterly. Always confirm with the lab or your GP before collection.
Normal AMH ranges in Australia by age
AMH peaks around age 25 and declines steadily thereafter — typically by about 1 pmol/L per year through the 30s, accelerating into the 40s. This means a result of "8 pmol/L" is low at 25 but unremarkable at 42.
| Age | Typical AMH (pmol/L) | What it suggests |
|---|---|---|
| 25 | ~21 (range 13–35) | Peak ovarian reserve |
| 30 | ~18 (range 10–30) | Good reserve |
| 35 | ~11 (range 5–22) | Declining reserve |
| 40 | ~7 (range 2–15) | Diminished reserve |
| 45+ | <3 (often undetectable) | Approaching menopause |
General interpretation, independent of age:
- AMH <11–14 pmol/L — suggests diminished ovarian reserve (DOR). Common in late 30s and beyond; investigated as POI in women under 40.
- AMH 14–25 pmol/L — normal range for most reproductive-age women
- AMH >30 pmol/L — elevated, often suggestive of PCOS (especially with irregular cycles, acne or hirsutism). High AMH alone does not diagnose PCOS — Rotterdam criteria require 2 of 3 (irregular cycles, hyperandrogenism, polycystic ovaries on ultrasound).
Always interpret your AMH against your age and clinical context, not the lab''s adult-wide range.
What AMH does — and does not — tell you
AMH is the single most useful blood test for ovarian reserve, but it has important limitations:
- AMH measures egg quantity, not quality. A 38-year-old with an AMH of 18 has good egg numbers but the eggs themselves have the chromosomal-error risk of a 38-year-old. Age is the dominant predictor of egg quality.
- One low AMH does not mean you are infertile. Women with low AMH frequently conceive naturally. AMH predicts IVF response (how many eggs can be retrieved) better than it predicts natural conception.
- One high AMH does not diagnose PCOS. Elevated AMH is a feature of PCOS but needs to be interpreted alongside cycle history, androgens and ultrasound findings.
- Hormonal contraception can suppress AMH — typically by 20–30% on the combined pill, implant or hormonal IUD. If you have been on hormonal contraception for years, your AMH may rebound after stopping. Allow ~3 months off hormonal contraception before testing for an accurate baseline.
- AMH cannot tell you when you will reach menopause with precision. It correlates with menopause timing on a population level but the individual prediction is wide.
Should you get an AMH test?
The most common scenarios in Australia:
- You are trying to conceive and have been unsuccessful for 6+ months (12+ months if under 35) — AMH is part of the standard fertility workup. Medicare may rebate depending on documentation.
- You have irregular cycles or signs of PCOS — AMH is highly informative. Medicare-rebate eligible.
- You are considering egg freezing — AMH predicts how many eggs you might harvest per cycle. Almost always self-funded.
- You are over 35 and unsure of your fertility timeline — AMH can help inform timing decisions, though it is not a fertility crystal ball. Usually self-funded.
- You are about to start chemotherapy — baseline AMH guides fertility-preservation planning. Medicare-rebate eligible.
If you are asymptomatic, under 30 and not actively trying to conceive, the clinical value of AMH testing is limited — most women under 30 have ample ovarian reserve and a single number tells you little that age alone does not already imply.
How to book an AMH test in Australia
- See your GP and discuss your reason for testing. If you have a Medicare-eligible indication (PCOS workup, irregular cycles, POI), make sure your GP documents it on the request form.
- Ask about 4Cyte Pathology if cost is a concern — request your GP routes the collection there if possible (4Cyte has collection centres in VIC and NSW).
- If 4Cyte is not available locally, expect $80–$120 out-of-pocket at any other major lab unless a clinical indication is documented and the lab applies the Medicare rebate.
- Collection: any day of the menstrual cycle, no fasting required, results typically back in 3–5 business days.
Related blood tests for fertility assessment
AMH is one piece of a fertility workup. The standard fertility panel in Australia also includes:
- FSH and LH (day 2–4 of cycle) — pituitary signals; rising FSH with low AMH suggests POI
- Oestradiol (day 2–4) — paired with FSH to interpret
- Prolactin and TSH — common reversible causes of ovulatory disturbance
- Day-21 progesterone — confirms ovulation
- Pelvic ultrasound — antral follicle count complements AMH
For more on related markers, see the TSH, Oestradiol and Ferritin entries in our glossary. For PCOS-specific testing, see our PCOS blood test guide and how to get tested for PCOS in Australia.
Tracking your AMH and full fertility panel over time
If you are going to invest in fertility testing, tracking is critical. A single AMH at 8 pmol/L is hard to interpret in isolation; an AMH that has dropped from 15 to 8 over three years tells you the rate of decline, which is far more clinically meaningful than the single value.
BloodTrack reads any Australian pathology PDF (including AMH from 4Cyte, Laverty, ACL, SNP, Dorevitch, QML, DHM, WDP), maps results to age-appropriate reference ranges, and charts every marker over time. Upload your fertility panel, no account needed for your first analysis.
Medical disclaimer: This article is for educational purposes only and is not medical advice. Fertility assessment is highly individual — always discuss your AMH results and reproductive planning with your GP or a fertility specialist.